Prof. Susanna Esposito is Full Professor of Pediatrics at the School of Medicine of the University of Parma, Italy. She is President and Founder of the World Association for Infectious Diseases and Immunological Disorders (WAidid), a position she has held since 2014, and Chair of the Committee on Infectious Diseases of the Italian Society of Pediatrics

In this issue’s Coffee with the Expert, we are honored to welcome Prof. Susanna Esposito who is Full Professor of Pediatrics at the Department...

A summary of the latest News & Alerts in the fields of vaccinology, vaccines, vaccination, and vaccine-preventable diseases. We curate the latest information on regulatory updates, emerging trends, breakthroughs in vaccine technology, vaccine safety and efficacy, global immunization developments and outbreak alerts, as a resource to keep our community informed.

Latest impactful scientific publications that stand out for their potential bearing on healthcare. We introduce groundbreaking research findings, innovative treatment modalities, results from phase 1 to 3 vaccine clinical trials, or paradigm-shifting discoveries that redefine our understanding of infectious diseases and therapeutic approaches for all vaccine-preventable diseases.

War destroys far more than buildings. It fractures health systems, displaces families, interrupts electricity and refrigeration, separates children from vaccination records, drives health workers...

Streptococcus pneumoniae remains a major cause of vaccine-preventable morbidity and mortality worldwide. Despite the remarkable success of pediatric pneumococcal conjugate vaccination programs, pneumococcal disease continues to cause substantial burdens of invasive pneumococcal disease (IPD), community-acquired pneumonia, bacteremia, and meningitis among adults, particularly older individuals and those with chronic medical conditions.

The U.S. Food and Drug Administration’s (FDA’s) Center for Biologics Evaluation and Research (CBER) is responsible for regulating vaccine use in the United States. The general stages...

The emergence and re-emergence of multiple arboviral diseases represent an increasingly important global public health challenge. Changes in climate, urbanization, human mobility, vector distribution, and population susceptibility have contributed to the geographic expansion and increasing incidence of several arboviral infections. Recognizing this growing threat, the World Health Organization (WHO) launched the Global Arbovirus Initiative in 2022, with the objective of strengthening global preparedness, surveillance, prevention, and control of epidemic-prone arboviruses.